Trial of Miltuximab in Prostate, Other Cancers Gets Nod to Enroll Additional Patients
News
The first-in-human clinical trial assessing the safety and tolerability of Miltuximab (MIL-38) — a radiolabeled antibody designed to image prostate, bladder, and pancreatic ... Read more